← FDA Drug Approvals (Drugs@FDA)

TERBUTALINE SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA FARMACEUTICA · Approved 2009-05-20

Drug application

FDA Application #

ANDA078630

Application type

Abbreviated New Drug Application (Generic)

Brand name

TERBUTALINE SULFATE

Generic name

TERBUTALINE SULFATE

Active ingredients

TERBUTALINE SULFATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

HIKMA FARMACEUTICA

Manufacturer

Hikma Pharmaceuticals USA Inc.

First approval

2009-05-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown